Back

Value of combined cardiopulmonary exercise testing with stress echocardiography in the management of late effects cardio-oncology patients.

11 December 2024 (00:00 - 16:00)
Organised by: Logo
Congress Presentation Part of: Challenges in cardio oncology Stress Echocardiography EACVI Premium Access EuroEcho-Imaging 2024 European Association of Cardiovascular Imaging (EACVI)

About the speaker

Photo
Miss Kate Donovan

Barts Health NHS Trust, London (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
Can flax "milk" prevent chemotherapy mediated cardiotoxicity in women with breast cancer?
Professor D. Jassal (Manitoba, CA)
Abstract Slides
Presentation thumbnail
Dapagliflozin improves ejection fraction, radial/longitudinal strain and reduces systemic H-FABP and pro-inflammatory cytokines in models of dororubicin/trastuzumab induced cardiotoxicity
Doctor N. Maurea (Naples, IT)
Abstract Slides
Presentation thumbnail
Early detection of CTRCD by echocardiography among patients with breast cancer treated with anthracycline and trastuzumab stratified by HFA-ICOS risk classes
Professor H. Al Farhan (Baghdad, IQ)
Abstract Slides

Access the full session

Session thumbnail
Challenges in cardio oncology

The Event

Event poster

EuroEcho-Imaging 2024

11 December - 13 December 2024
You may be interested in
thumbnail
Congress Presentation
The do’s and don’ts from the EACVI clinical consensus statement on stress echocardiography
thumbnail
Congress Presentation
Stress echocardiography best defines risk
thumbnail
Congress Presentation
Valvular heart disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources